Anoikis-associated lung cancer metastasis: mechanisms and therapies
J Wang, Z Luo, L Lin, X Sui, L Yu, C Xu, R Zhang… - Cancers, 2022 - mdpi.com
Simple Summary Anoikis is a programmed cell death process resulting from the loss of
interaction between cells and the extracellular matrix. Therefore, it is necessary to overcome …
interaction between cells and the extracellular matrix. Therefore, it is necessary to overcome …
Anticancer and immunogenic properties of cardiac glycosides
NFZ Schneider, C Cerella, CMO Simões, M Diederich - Molecules, 2017 - mdpi.com
Cardiac glycosides (CGs) are natural compounds widely used in the treatment of several
cardiac conditions and more recently have been recognized as potential antitumor …
cardiac conditions and more recently have been recognized as potential antitumor …
Synthesis, antimicrobial, anticancer activities, PASS prediction, molecular docking, molecular dynamics and pharmacokinetic studies of designed methyl α-D …
Carbohydrates are abundant naturally occurring biomolecules that play essential roles in a
wide variety of biological processes. In this paper, we describe the synthesis of a series of …
wide variety of biological processes. In this paper, we describe the synthesis of a series of …
Cardiac glycosides: From molecular targets to immunogenic cell death
Cardiac glycosides (CGs) are approved for the treatment of cardiovascular alterations and
their known cellular target is the alpha subunit of the sodium (Na+)/potassium (K+)-ATPase …
their known cellular target is the alpha subunit of the sodium (Na+)/potassium (K+)-ATPase …
Non-canonical programmed cell death mechanisms triggered by natural compounds
M Diederich, C Cerella - Seminars in cancer biology, 2016 - Elsevier
Natural compounds are the fundament of pharmacological treatments and more than 50% of
all anticancer drugs are of natural origins or at least derived from scaffolds present in Nature …
all anticancer drugs are of natural origins or at least derived from scaffolds present in Nature …
Na/K pump and beyond: Na/K-ATPase as a modulator of apoptosis and autophagy
C Felippe Gonçalves-de-Albuquerque, A Ribeiro Silva… - Molecules, 2017 - mdpi.com
Lung cancer is a leading cause of global cancer deaths. Na/K-ATPase has been studied as
a target for cancer treatment. Cardiotonic steroids (CS) trigger intracellular signalling upon …
a target for cancer treatment. Cardiotonic steroids (CS) trigger intracellular signalling upon …
Suppression of cancer stem-like phenotypes in NCI-H460 lung cancer cells by vanillin through an Akt-dependent pathway
S Srinual, P Chanvorachote… - … journal of oncology, 2017 - spandidos-publications.com
Cancer stem cells (CSCs) have been reported as a major cause of cancer metastasis and
the failure of cancer treatment. Cumulative studies have indicated that protein kinase B (Akt) …
the failure of cancer treatment. Cumulative studies have indicated that protein kinase B (Akt) …
Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450
Cardiac glycosides (CGs), prescribed to treat cardiovascular alterations, display potent anti-
cancer activities. Despite their well-established target, the sodium/potassium (Na+/K+) …
cancer activities. Despite their well-established target, the sodium/potassium (Na+/K+) …
Cardiac glycoside glucoevatromonoside induces cancer type-specific cell death
NFZ Schneider, C Cerella, JY Lee… - Frontiers in …, 2018 - frontiersin.org
Cardiac glycosides (CGs) are natural compounds used traditionally to treat congestive heart
diseases. Recent investigations repositioned CGs as potential anticancer agents. To …
diseases. Recent investigations repositioned CGs as potential anticancer agents. To …
Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status
J Poohadsuan, GA O'Doherty… - Cell Communication and …, 2023 - Springer
Background Acute myeloid leukemia (AML) is an aggressive hematologic malignancy
characterized by an accumulation of immature leukemic myeloblasts initiating from leukemic …
characterized by an accumulation of immature leukemic myeloblasts initiating from leukemic …